Relationship between serum butyrylcholinesterase and obesity in dogs: A preliminary report

Veterinary Journal

Volumn 186, Issue 2, 2010, Pages 197-200

  Tvarijonaviciute, Asta ^a   Tecles, Fernando ^a   Ceron, José J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Adiponectin; Butyrylcholinesterase; Cholesterol; Dog; Obesity

Indexed keywords

ADIPONECTIN; BIOCHEMICAL MARKER; CHOLINESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE MARKER; DOG DISEASE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FEMALE; LIPID BLOOD LEVEL; MALE; NONHUMAN; OBESITY; SCORING SYSTEM; THORAX; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADIPONECTIN; ANIMALS; BIOLOGICAL MARKERS; BODY CONSTITUTION; BODY WEIGHT; BUTYRYLCHOLINESTERASE; CHOLESTEROL; DOG DISEASES; DOGS; FEMALE; MALE; OBESITY; THORAX; WAIST CIRCUMFERENCE;

CANIS FAMILIARIS;

EID: 78149412246     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.07.030     Document Type: Article

References (26)

1. Abdelkader S.V., Hauge J.G. Serum enzyme determination in the study of liver disease in dogs. Acta Veterinaria Scandinavica 1986, 27:59-70.
2. Alcatara V.M., Oliveira L.C., Rea R.R., Suplicy H.L., Chautard-Feire-Maia E.A. Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5 - phenotypes. International Journal of Obesity 2003, 27:1557-1564.
3. Atkinson J.E., Bolte H.F., Rubin L.F., Sonawane M. Assessment of ocular toxicity in dogs during six months exposure to a potent organophosphate. Journal of Applied Toxicology 1994, 14:145-152.
4. Augustinsson K.B., Eriksson H., Faijersson Y. A new approach to determining cholinesterase activities in samples of whole blood. Clinica Chimica Acta 1978, 89:239-252.
5. Briand F., Bailhache E., Andre A., Magot T., Krempf M., Nguyen P., Ouguerram K. The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance. kinetic study using stable isotopes. Metabolism Clinical and Experimental 2008, 57:966-972.
6. Brunson B.L., Zhong Q., Clarke K.J., Bedi D., Braden T.D., van Santen E., Judd R.L. Serum concentrations of adiponectin and characterization of adiponectin protein complexes in dogs. American Journal of Veterinary Research 2007, 68:57-62.
7. Burkholder W.J., Toll P.W. Obesity. Small Animal Clinical Nutrition 2000, 401-430. Mark Morris Institute, Topeka, KS, USA. fourth edition. K.S. Topeka (Ed.).
8. Calderon-Margalit R., Adler B., Abramson J.H., Gofin J., Kark J. Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and woman in Jerusalem. Clinical Chemistry 2006, 52:845-852.
9. Cuauianu M., Nistor T., Hancu N., Orbai P., Muscurel C., Stoian I. Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes. Romanian Journal of Internal Medicine 2002, 40:43-51.
10. Dass P., Mejia M., Landes M., Jones R., Stuart B., Thyssen J. Cholinesterase: review of methods. Clinical Chemistry 1994, 10:135-157.
11. Furlanello T., Simonato G., Caldin M., De Lorenzi D., Lubas G., Bernardini D., Solano-Gallego L. Validation of an automated spectrophotometric assay for the determination of cholinesterase activity in canine serum. Veterinary Research Communications 2006, 30:723-733.
12. German A.J. The growing problem of obesity in dogs and cats. The Journal of Nutrition 2006, 136:1940S-1946S.
13. Ishioka K., Omachi A., Sagawa M., Shibata H., Honjoh T., Kimura K., Saito M. Canine adiponectin: cDNA structure, mRNA expression in adipose tissues and reduced plasma levels in obesity. Research in Veterinary Science 2006, 80:127-132.
14. Ishioka K., Soliman M.M., Sagawa M., Nakadomo F., Shibata H., Honjoh T., Hashimoto A., Kitamura H., Kimura K., Saito M. Experimental and clinical studies on plasma leptin in obese dogs. Journal of Veterinary Medical Science 2002, 64:349-353.
15. Iwasaki T., Yoneda M., Nakajima A., Terauchi Y. Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Internal Medicine 2007, 46:1633-1639.
16. Jeusette I., Daminet S., Nguyen P., Shibata H., Saito M., Honjoh T., Istasse L., Diez M. Effect of ovariectomy and ad libitum feeding on body composition, thyroid status, ghrelin and leptin plasma concentrations in female dogs. Journal of Animal Physiology and Animal Nutrition 2006, 90:12-18.
17. Jope R.S., Walter-Ryan W.G., Alcaron R.D., Lally K.M. Cholinergic processes in blood samples from patients with psychiatric disorders. Biological Psychiatry 1985, 20:1258-1266.
18. Kaplay S.S. Acetylcholinesterase and butyrylcholinesterase of developing human brain. Biology of the Neonate 1976, 28:65-73.
19. Laflamme P.D. Development and validation of a body condition score system for dogs. Canine Practice 1997, 22:10-15.
20. Magarian E.O., Dietz A.J. Correlation of cholinesterase with serum lipids and lipoproteins. The Journal of Clinical Pharmacology 1987, 27:819-820.
21. Munro N.B., Shugart L.R., Watson A.P., Halbrook R.S. Cholinesterase activity in domestic animals as a potential biomonitoring for nerve agent and other organophosphate exposure. Journal of the American Veterinary Medical Association 1991, 199:103-115.
22. Randell E.W., Mathews M.S., Zhang H., Seraj J.S., Sun G. Relationship between serum butyrylcholinesterase and methabolic syndrome. Clinical Biochemistry 2005, 38:799-805.
23. Sagawa M.M., Nakadomo F., Honjoh T., Ishioka K., Saito M. Correlation between plasma leptin concentration and body fat content in dogs. American Journal of Veterinary Research 2002, 63:7-10.
24. Sakaguchi K., Nagayama M., Masaoka T., Nishimura A., Kageyama K., Shirai M., Akahori F. Effects of fenthion, isoxathion, dichlorvos and propaphos on the serum cholinesterase isoenzyme patterns of dogs. Veterinary Human Toxicology 1997, 39:1-5.
25. Tecles F., Martinez-Subiela S., Bernal L.J., Ceron J.J. Use of whole blood for spectrophotometric determination of cholinesterase activity in dogs. The Veterinary Journal 2000, 160:242-249.
26. Vaisi-Raygani A., Rahimi Z., Kharazi H., Tavilani H., Aminiami M., Kiani A., Vaisi-Raygani A., Pourmotabbed T. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran. Clinical Biochemistry 2007, 40:629-633.